Keytruda Biosimilar FDA Review: FYB206 BLA Accepted
FDA has accepted the Zydus and Formycon FYB206 BLA for review, the first publicly announced Keytruda biosimilar filing. Decision possible in Q3 2027.
FDA has accepted the Zydus and Formycon FYB206 BLA for review, the first publicly announced Keytruda biosimilar filing. Decision possible in Q3 2027.